The
Female Health Company Reports:
The Female Health Company Reports Purchase of Shares
by Director
The Female Health Company reported that Stephen M. Dearholt, a
director, has purchased 276,667 shares of its common stock during the
last 30 days. Mr. Dearholt’s aggregate beneficial ownership now totals
1,769,451 shares of the Company’s common stock.
The Female Health Company, based in Chicago, owns certain worldwide
rights to the Female Condom including patents which have been issued in
the United States, United Kingdom, Japan, France, Italy, Germany, Spain,
The People’s Republic of China, Canada, New Zealand, South Korea and
Australia. The Female Condom is the only available product controlled by
a woman that protects against sexually transmitted diseases including
HIV/AIDS, and unintended pregnancy.
"Safe Harbor" Statement under the Private Securities
Litigation Reform Action of 1995: The statement in this
release which are not historical fact are forward-looking statements
based upon the Company’s current plans and strategies, and reflect the
Company’s current assessment of the risks and uncertainties related to
its business, including such things as product demand and market
acceptance; the economic and business environment and the impact of
governmental regulations, both in the United States and abroad; the
effects of competitive products and pricing pressures; currency risks;
capacity; efficiency and supply constraints; and other risks detailed in
the Company’s press releases, shareholder communication and Securities
and Exchange Commission filings. Actual events affecting the Company and
the impact of such events on the Company’s operations may vary from
those currently anticipated.
For more information about The Female Health Company
toll-free via fax,
dial 1-800-PRO-INFO and enter company code "FHCO."
Also, visit the Company's web site,
www.femalehealth.com.
# # #